ESG News For Alkermes, Inc.

Our employees are the foundation upon which our business is built. Their expertise, intelligence and creativity drive our innovation, and their passion and commitment to excellence are the cornerstone of our success.

Our Board is currently comprised of eleven members, each of whom has a term expiring at the Company’s 2024 annual general meeting of shareholders.

Integrity is a core Alkermes value and the foundation of the way we do business. Alkermes is dedicated to upholding legal, regulatory and ethical standards in the markets in which we operate and to maintaining a strong culture of compliance.

Employee engagement remained a top priority for the Company throughout 2022. As many of our office-based employees have adapted to a hybrid work model, we’ve continued the innovative communications strategies developed throughout the COVID-19 pandemic to keep employees connected.

We have developed and now manufacture and commercialize proprietary medicines for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder - disease areas with vulnerable patient populations who are often treated in public health.

Landmark Concert—Now In Its Second Year—Will Feature Smith & Myers, Jason Isbell, Kiiara, American Authors, Jade Bird, Yola, Shamir, Son Little, And More With Jordan Carlos As HostSpecial Event Will Broadcast Live On The Relix YouTube Channel At 8 P.M. ET/5 P.M. PT